Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSTAT: Vadadustat for ARDS in COVID-19
NCT04478071Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vadadustat in acute respiratory distress syndrome (ARDS), coronavirus disease 2019 (COVID-19), sponsored by UTHealth Houston. Started Aug 2020; status: completed.
02
Drugs
vadadustat
03
Conditions
acute respiratory distress syndrome (ARDS)coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04478071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478071.